| Product ID | 83021-774_eb04d402-e750-6281-e053-2995a90a5ef3 |
| NDC | 83021-774 |
| Product Type | Human Otc Drug |
| Proprietary Name | AnubisMed |
| Generic Name | Aloe Barbadensis Leaf Extract, Propylene Glycol, Cetearyl Ethylhexanoate |
| Dosage Form | Cream |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2022-10-14 |
| Marketing Category | OTC MONOGRAPH FINAL / |
| Application Number | M016 |
| Labeler Name | ANUBIS COSMETICS SL |
| Substance Name | 1,2-HEXANEDIOL; ALLANTOIN; ALOE VERA LEAF; ARGAN OIL; BUTYLATED HYDROXYTOLUENE; BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES; C12-20 ACID PEG-8 ESTER; CAPRYLYL GLYCOL; CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; DECYL OLEATE; FRAGRANCE 13576; GLYCERIN; GRAPE SEED OIL; HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER; IMIDUREA; MEDIUM-CHAIN TRIGLYCERIDES; PROPYLENE GLYCOL; SILICON DIOXIDE; TOCOPHEROL; TROLAMINE; TROPOLONE; WATER |
| Active Ingredient Strength | 0 g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; mL/15mL |
| Pharm Classes | Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |